Skip to main content


Based on research out of Prof. Nathan Gianneschi's lab,  Grove Biopharma is a breakthrough platform biotechnology startup, operating at the interface between materials science and biotherapeutics, pioneering the discovery and development of a new class of proteomimetic drug modality for challenging drug targets with the potential to address significant unmet medical needs in chronic inflammatory and neurodegenerative diseases.

We are looking for an energetic, motivated, principal research scientist to join our founding, multidisciplinary R&D team to lead the discovery of novel biomacromolecular therapeutics to treat human diseases. This peptide chemistry expert will be responsible for the design, synthesis, and analysis of peptide-based bioconjugates and macromolecules. The applicant will report to the CTO and will have close interactions with the executive team and collaborators. This role demands a highly goal-driven approach and the ability to focus on time-sensitive objectives to meet milestones. A demonstrated, deep understanding of peptide synthesis, synthetic chemistry, analytical chemistry, purification techniques, and processing technologies is critical.

Please apply directly through LinkedIn or send CV/resume and cover letter (~1 page) to: Paul Bertin, PhD, President and CTO (




Grove Biopharma is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex, gender identity, sexual orientation, national origin, disability, protected veteran status or any other characteristic protected by local, state or federal laws, rules or regulations.

CONTACT:  Paul Bertin (  

posted July 27, 2021